ArticleFrontiers in pharmacology2022

Ginsenoside Rg1 interferes with the progression of diabetic osteoporosis by promoting type H angiogenesis modulating vasculogenic and osteogenic coupling.

Wenhui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.